|
METTL2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.943900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.372620E-01 |
| Normal-vs-Stage2 |
1.097580E-01 |
| Normal-vs-Stage3 |
6.15549999999354E-05 |
| Normal-vs-Stage4 |
3.764400E-03 |
| Stage1-vs-Stage2 |
4.807200E-01 |
| Stage1-vs-Stage3 |
9.401100E-04 |
| Stage1-vs-Stage4 |
2.904200E-02 |
| Stage2-vs-Stage3 |
1.118390E-01 |
| Stage2-vs-Stage4 |
3.421200E-01 |
| Stage3-vs-Stage4 |
5.843800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.295900E-03 |
| Normal-vs-AfricanAmerican |
2.239700E-04 |
| Normal-vs-Asian |
1.851970E-01 |
| Caucasian-vs-AfricanAmerican |
5.097800E-02 |
| Caucasian-vs-Asian |
7.459100E-03 |
| AfricanAmerican-vs-Asian |
3.467900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.839000E-03 |
| Normal-vs-Female |
2.790000E-02 |
| Male-vs-Female |
5.341200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.730990E-01 |
| Normal-vs-Age(41-60Yrs) |
1.374160E-02 |
| Normal-vs-Age(61-80Yrs) |
1.012420E-02 |
| Normal-vs-Age(81-100Yrs) |
8.239600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.753200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.383600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.325200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.685000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.631800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.146600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.166800E-01 |
| Normal-vs-Grade 2 |
6.980400E-02 |
| Normal-vs-Grade 3 |
2.084600E-03 |
| Normal-vs-Grade 4 |
2.284300E-03 |
| Grade 1-vs-Grade 2 |
5.314600E-01 |
| Grade 1-vs-Grade 3 |
2.399200E-01 |
| Grade 1-vs-Grade 4 |
1.659230E-01 |
| Grade 2-vs-Grade 3 |
1.039210E-01 |
| Grade 2-vs-Grade 4 |
3.619800E-02 |
| Grade 3-vs-Grade 4 |
3.495800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.031400E-01 |
| Normal-vs-ccB subtype |
5.502000E-03 |
| ccA subtype-vs-ccB subtype |
2.110100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.336000E-02 |
| Normal-vs-N1 |
7.483800E-01 |
| N0-vs-N1 |
7.684800E-01 |
|
|
